Patents by Inventor Kartik Temburnikar

Kartik Temburnikar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NRTI THERAPIES
    Publication number: 20220072138
    Abstract: Polymer-of-prodrug (POP) materials enable new nucleoside reverse transcriptase inhibitor (NRTI) therapy strategies. The materials are prodrugs of NRTIs in the form of polymers. Suitable materials include products which are polymeric NRTI delivery systems comprising polymeric materials which are capable of degradation after administration to release NRTIs or NRTI prodrugs which themselves are capable of metabolism to the parent NRTIs. The NRTIs may optionally be selected from tenofovir (TFV), emtricitabine (FTC), lamivudine (3TC) and MK-8591 (EFdA). The invention facilitates long-acting (LA) regimens. Constructs of the materials may be in the form of injectable compositions or implants.
    Type: Application
    Filed: December 20, 2019
    Publication date: March 10, 2022
    Inventors: Andrew OWEN, Steve RANNARD, Faye HERN, Chung LIU, Anika SHAKIL, Megan NEARY, Caren Freel MEYERS, Kartik TEMBURNIKAR, Lauren BAMBARGER, Stephanie HENRIQUEZ
  • Thieno- and pyrrolopyrimidine analogues as anticancer agents and methods of use thereof
    Patent number: 10561658
    Abstract: The present invention provides for the design and synthesis of halogenated thieno- and pyrrolopyrimidine compounds that exhibit cancer proliferation inhibitory activity and the use thereof for cancer treatment.
    Type: Grant
    Filed: February 12, 2018
    Date of Patent: February 18, 2020
    Assignee: UNIVERSITY OF MARYLAND, BALTIMORE COUNTY
    Inventors: Katherine L. Radtke, Kartik Temburnikar
  • THIENO- AND PYRROLOPYRIMIDINE ANALOGUES AS ANTICANCER AGENTS AND METHODS OF USE THEREOF
    Publication number: 20180161330
    Abstract: The present invention provides for the design and synthesis of halogenated thieno- and pyrrolopyrimidine compounds that exhibit cancer proliferation inhibitory activity and the use thereof for cancer treatment.
    Type: Application
    Filed: February 12, 2018
    Publication date: June 14, 2018
    Inventors: KATHERINE L. RADTKE, KARTIK TEMBURNIKAR
  • Thieno- and pyrrolopyrimidine analogues as anticancer agents and methods of use thereof
    Patent number: 9895374
    Abstract: The present invention provides for the design and synthesis of halogenated thieno- and pyrrolopyrimidine compounds that exhibit cancer proliferation inhibitory activity and the use thereof for cancer treatment.
    Type: Grant
    Filed: August 29, 2016
    Date of Patent: February 20, 2018
    Assignee: UNIVERSITY OF MARYLAND, BALTIMORE COUNTY
    Inventors: Katherine L. Radtke, Kartik Temburnikar
  • THIENO- AND PYRROLOPYRIMIDINE ANALOGUES AS ANTICANCER AGENTS AND METHODS OF USE THEREOF
    Publication number: 20170014415
    Abstract: The present invention provides for the design and synthesis of halogenated thieno- and pyrrolopyrimidine compounds that exhibit cancer proliferation inhibitory activity and the use thereof for cancer treatment.
    Type: Application
    Filed: August 29, 2016
    Publication date: January 19, 2017
    Inventors: KATHERINE L. RADTKE, KARTIK TEMBURNIKAR
  • Thieno- and pyrrolopyrimidine analogues as anticancer agents and methods of use thereof
    Patent number: 9434742
    Abstract: The present invention provides for the design and synthesis of halogenated thieno- and pyrrolopyrimidine compounds that exhibit cancer proliferation inhibitory activity and the use thereof for cancer treatment.
    Type: Grant
    Filed: March 2, 2015
    Date of Patent: September 6, 2016
    Assignee: UNIVERSITY OF MARYLAND, BALTIMORE COUNTY
    Inventors: Katherine L. Radtke, Kartik Temburnikar